Simultaneous Determination of Gamma-Hydroxybutyric Acid (GHB) and Gamma-Butyrolactone (GBL) in Beverages

Chromatography

Simultaneous Determination of Gamma-Hydroxybutyric Acid (GHB) and Gamma-Butyrolactone (GBL) in Beverages

12 Jul, 2010

Published over 16 years ago. See the latest and most current information on Chromatography.

Drug Facilitated Crime (DFC) and Drug-Facilitated Sexual Assault (DFSA) in particular have become threats to partygoers in nightspots in many places. Prosecution depends on the successful detection of gammahydroxybutyrate (GHB) and its prodrug gamma-butyrolactone (GBL), the substances most commonly used to spike beverages to make the victim defenceless. Metrohm offers a straightforward and fast ionchromatographic method to determine both substances in a single run.

For the forensic determination of illegally added GHB and GBL in commonly consumed beverages, this method employs direct-injection ion chromatography combined with spectrophotometric detection. In the range of 10

to 200 mg/L, five-point calibration curves for GHB and GBL yield correlation coefficients of 0.9998 and 0.9997, respectively.

Spiking experiments in which GHB and GBL were added to alcoholic beverages and non-alcoholic fruit juices showed no matrix effects. The method allows to trace GHB-GBL interconversion, whether in-vivo or in-vitro

lactone cleavage or intramolecular GHB esterification, and thus complies with pertinent requirements of law enforcement agencies.

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Measurement to mitigation in the next evolution of emissions monitoring
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
Fifty years on, the EU reaffirms its commitment to Seveso-level industrial safety oversight
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow